← All Sponsors
SPONSOR

Iovance Biotherapeutics, Inc.

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Melanoma (Skin Cancer)Unresectable MelanomaMetastatic Melanoma
NCT07288203 Phase 2
Recruiting

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma

Melanoma (Skin Cancer)
United States, Australia, Canada View Trial →